Proteomedix enables personalized medicine by developing non-invasive diagnostic tests to detect and assess the prognosis of cancer, as well as to match patients with safer and more effective therapies.
The first product is a blood-based test for the early diagnosis of prostate cancer. The main benefit of this test is a significantly higher accuracy compared to today’s clinical standard (blood-based PSA test). This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Wagistrasse 21, Schlieren,8952,switzerland
- Phone
- 41 44 733 40 90
- in****@****dix.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- proteomedix.com
- HQ
- Schlieren
Proteomedix Ag Questions
Proteomedix Ag's helpline number is 41 44 733 40 90
Proteomedix Ag's website is proteomedix.com
Proteomedix Ag's LinkedIn profile is https://ch.linkedin.com/company/proteomedix-ag
Proteomedix Ag has
6 employees.
View email and phone details for 6
employees at Proteomedix Ag.
Proteomedix Ag's industry is
Biotechnology Research
Proteomedix Ag's top competitors are
Repertoire Immune Medicines,
Ontrack Biomedical Ag,
Virometix Ag,
Novago Therapeutics,
Swiss Bioscience Gmbh,
Mabylon Ag,
Pharmabiome Ag,
Neurimmune Ag,
Redbiotec Ag,
Biognosys.
Proteomedix Ag's support email address is info@proteomedix.com
Proteomedix Ag's categories are Biotechnology Research
Proteomedix Ag's founding year is 2010
